Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,067 | 2,216 | 929 | 2,590 | 2,782 |
| TOTAL | $8,186 | $3,038 | $1,651 | $3,363 | $3,787 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,399 | 1,405 | 1,414 | 1,420 | 1,426 |
| TOTAL | $1,399 | $1,405 | $1,414 | $1,420 | $1,426 |
| Total Assets | $9,585 | $4,443 | $3,065 | $4,783 | $5,213 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,684 | 1,193 | 1,586 | 1,219 | 540 |
| Accrued Expenses | 561 | 941 | 1,014 | 508 | 1,749 |
| TOTAL | $2,276 | $2,164 | $2,629 | $1,755 | $2,317 |
| Non-Current Liabilities | |||||
| TOTAL | $87 | $95 | $102 | $110 | $117 |
| Total Liabilities | $2,363 | $2,259 | $2,731 | $1,865 | $2,434 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,065 | 47,058 | 18,398 | 15,181 | 13,868 |
| Common Shares | 5 | 3 | 2 | 2 | 1 |
| Retained earnings | -75,338 | -72,667 | -70,130 | -66,783 | -63,602 |
| TOTAL | $7,222 | $2,184 | $334 | $2,918 | $2,779 |
| Total Liabilities And Equity | $9,585 | $4,443 | $3,065 | $4,783 | $5,213 |